期刊文献+

血清胱抑素C在冠心病冠脉病变评估中的价值 被引量:1

下载PDF
导出
摘要 目的观察冠心病(CAD)患者血清胱抑素C(Cys C)水平,评估血清Cys C与冠状动脉病变的相关性。方法收集121例于我院行冠状动脉造影检查的患者,并根据造影结果分为CAD组和非CAD组,CAD组又根据冠脉病变支数分为单支、双支及多支病变亚组,采用Gensini评分系统对每支冠状动脉病变程度进行评分。检测所有入组患者血清Cys C水平,分析血清Cys C与冠脉病变程度的相关性。结果 CAD组与非CAD组血清Cys C水平(1.17 mg/L±0.33 mg/L vs 0.76 mg/L±0.21 mg/L)差异具有统计学意义(P<0.05);冠脉单支、双支及多支病变亚组之间Cys C水平(0.91 mg/L±0.26 mg/L vs 1.12 mg/L±0.31 mg/L vs 1.22mg/L±0.31mg/L)差异具有统计学意义(P<0.05),且随冠脉病变支数的增加而增高;血清CysC水平与Gensini评分呈正相关(r=0.313,P<0.05)。结论血清Cys C水平在CAD患者中显著升高,可作为冠状动脉病变程度评估的有用指标。
作者 郑风林
出处 《中西医结合心脑血管病杂志》 2015年第9期1099-1100,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献10

  • 1Lala A,Desai AS. The role of coronary artery disease in heart failure[J]. Heart Fail Clin,2014,10(2) : 353- 365.
  • 2Ferraro S, Marano G, Biganzoli EM, et al. Prognostic value of cystatin C in acute coronary syndromes: Enhancer of athero- sclerosis and promising therapeutic target [J]. Clin Chem Lab Med,2011,49(9) ; 1397 - 1404.
  • 3Angelidis C, Deftereos S, Giannopoulos G, et al. Cystatin C, An emerging biomarker in cardiovascular disease[J]. Curr Top Med Chem,2013, 13(2), 164- 179.
  • 4Duchatelle V, Kritikou EA, Tardif JC. Clinical value of drugs tar geting inflammation for the management of coronary artery dis ease[J]. Can J Cardiol, 2012,28(6), 678 - 686.
  • 5McPherson R,Davies RW. Inflammation and coronary artery disease, Tinsights from genetic studiesFJ]. Can J Cardiol, 2012, 28(6) : 662 - 666.
  • 6Doganer YC,Aydogan U,Aydogdu A, et al. Relationship of cys- tatin C with coronary artery disease and its severity[J]. Coro nartery Dis,2013,24(2) : 119- 126.
  • 7Kiyosue A, Hirata Y,Ando J, et al. Plasma cystatin C concentra- tion reflects the severity of coronary artery disease in patients without chronic kidney disease[J]. Circ J, 2010, 74(11), 2441 -2447.
  • 8Koenig W, Twardella D, Brenner H, et al. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate[J]. Clin Chem, 2005,51 (2): 321 - 327.
  • 9Noto D,Cefalu AB, Barbagallo CM, et al. Cystatin C levels are decreased in acute myocardial infarction, Effect of cystatin C G73A gene polymorphism on plasma levels[J]. Int J Cardioh 2005,101(2) :213-217.
  • 10Tousoulis D, Kampoli AM, Stefanadi E, et al. New biochemical markers in acute coronary syndromes[J]. Curr Med Chem, 2008,15( 13), 1288 - 1296.

同被引文献14

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部